Encompass Health (EHC)
NYSE:EHC
Want to see EHC full AI Analyst Report?
EHC Stock Chart & Stats
$106.39
$0.72(0.79%)
At close: 4:00 PM EST
$106.39
$0.72(0.79%)
Day’s Range― - ―
52-Week Range$92.77 - $127.99
Previous CloseN/A
Volume95.02K
Average Volume (3M)931.58K
Market Cap
$10.69B
Enterprise Value$12.81B
Total Cash (Recent Filing)$110.50M
Total Debt (Recent Filing)$258.50M
Price to Earnings (P/E)12.3
Beta0.57
Next Earnings
Aug 04, 2026EPS Estimate
1.48Next Dividend Ex-DateN/A
Dividend Yield0.65%
Share Statistics
EPS (TTM)1.60
Shares Outstanding99,416,160
10 Day Avg. Volume1,070,147
30 Day Avg. Volume931,583
Financial Highlights & Ratios
PEG Ratio0.78
Price to Book (P/B)4.37
Price to Sales (P/S)1.80
P/FCF Ratio24.29
Enterprise Value/Market Cap1.20
Enterprise Value/Revenue2.11
Enterprise Value/Gross Profit3.59
Enterprise Value/Ebitda8.88
Forecast
1Y Price Target
$145.50Price Target Upside36.76% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)5.92
Revenue Forecast (FY)$6.42B
Bulls Say, Bears Say
Bulls Say
Capacity ExpansionManagement plans to add capacity through smaller-format hospitals and new facilities to offset closed sites and capture unmet patient demand, supporting revenue growth.
Medicare Payment OutlookThe proposed Medicare payment update combined with unchanged analyst pricing assumptions suggests a net improvement in revenue per discharge and supports forward revenue estimates.
Operational Performance And MarginsReported EBITDA beat expectations and improving profit margins driven by stronger discharge volumes and pricing underpin analyst buy recommendations and confidence in earnings durability.
Bears Say
Capital Spending And Cash Flow PressureHigher maintenance and development spending to expand and sustain facilities is likely to restrain adjusted free cash flow growth, limiting cash available for other uses.
Near-term Volume HeadwindsClosures and consolidations of inpatient rehabilitation facilities are expected to create a temporary headwind to same-store discharge growth and have led analysts to trim near-term revenue forecasts.
Payer Denials And Referral ConversionIncreased denials and reduced referral-to-admission conversion from a major Medicare Advantage payor pose a risk to admissions and require appeals and regulatory engagement to protect volumes.
Encompass Health News
EHC FAQ
What was Encompass Health’s price range in the past 12 months?
Encompass Health lowest stock price was $92.77 and its highest was $127.99 in the past 12 months.
What is Encompass Health’s market cap?
Encompass Health’s market cap is $10.69B.
When is Encompass Health’s upcoming earnings report date?
Encompass Health’s upcoming earnings report date is Aug 04, 2026 which is in 93 days.
How were Encompass Health’s earnings last quarter?
Encompass Health released its earnings results on Apr 30, 2026. The company reported $1.6 earnings per share for the quarter, beating the consensus estimate of $1.494 by $0.106.
Is Encompass Health overvalued?
According to Wall Street analysts Encompass Health’s price is currently Undervalued.
Does Encompass Health pay dividends?
Encompass Health pays a Quarterly dividend of $0.19 which represents an annual dividend yield of 0.65%. See more information on Encompass Health dividends here
What is Encompass Health’s EPS estimate?
Encompass Health’s EPS estimate is 1.48.
How many shares outstanding does Encompass Health have?
Encompass Health has 99,416,160 shares outstanding.
What happened to Encompass Health’s price movement after its last earnings report?
Encompass Health reported an EPS of $1.6 in its last earnings report, beating expectations of $1.494. Following the earnings report the stock price went up 7.48%.
Which hedge fund is a major shareholder of Encompass Health?
Currently, no hedge funds are holding shares in EHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Encompass Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$145.50 (36.76% Upside)
$145.50 (36.76% Upside)
Blogger Sentiment
Bullish
EHC Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 782.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $18.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
3.62%
12-Months-Change
Fundamentals
Return on Equity
24.48%
Trailing 12-Months
Asset Growth
8.49%
Trailing 12-Months
Company Description
Encompass Health
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
EHC Company Deck
EHC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple material operating and financial wins: double-digit EBITDA growth, revenue growth, improved clinical quality metrics, lower RN turnover, meaningful decline in premium labor, strong free cash flow and an expanded development pipeline. Offsetting these positives were manageable headwinds: short-term volume impact from unit closures (~85 bps), a one-time increase in bad debt tied to legacy claim write-offs, MA utilization variability, regulatory implementation risk and localized capacity constraints in high-demand markets. Management emphasized plans to address capacity via bed adds, de novos, joint ventures and small-format hospitals, and raised full-year guidance based on Q1 performance. Overall, positives materially outweighed the negatives.View all EHC earnings summariesEHC Stock 12 Month Forecast
Average Price Target
$145.50
▲(36.76% Upside)
Technical Analysis
DaVita
―
Fresenius Medical Care
―
Tenet Healthcare
―
The Ensign Group
―
Universal Health
―
Ownership Overview
1.20% Insiders
31.64% Mutual Funds
4.43% Other Institutional Investors
39.93% Public Companies and
Individual Investors